Substance Abuse Professional Program for DOT- SAP Evaluations

As an MRO, you have the following essential responsibilities:

• Acting as an independent and impartial "gatekeeper" and advocate for the accuracy and integrity of the DOT testing process.
• Providing a quality assurance review of the DOT testing process for the specimens being reviewed

Congress passed the Omnibus Transportation Employee Testing Act of 1991 because they recognized the safety need for ensuring DOT- and -free transportation employees. The "Act" required DOT Agencies to implement DOT testing of safety-sensitive transportation employees in the aviation, trucking (including school bus drivers and particular limousine and van drivers), railroads, mass transit, and pipelines industries.

1-Pre-employment testing: Occurs before hire or transfer into a safety-sensitive function.

Random testing: Unannounced on an ongoing basis, spread reasonably throughout the calendar year

Post-accident testing - Occurs following the modes qualifying accident.

Reasonable Cause/Suspicion testing - Occurs when a company official or supervisor believes the employee shows signs of DOT use and misuse.

Return-to-duty and Follow-up testing: Occurs after an employee has a verified positive DOT test, positive test result, or refusal to test. The employee must take a return-to-duty test before returning to safety-sensitive functions

You will be tested for the following DOT:

• Marijuana
• Cocaine
• Opioids (Codeine, morphine, heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone)
• Phencyclidine (PCP)
• Amphetamines, Methamphetamines, and Methylenedioxymethamphetamine (MDMA)

Refusals include, but are not limited to:

• No-show (failure to appear at the test collection site at the designated time)
• Failure to remain at the testing site until the collection is completed
• Adulteration (urine specimen containing a substance or a concentration of a substance inconsistent with human urine)
• Substitution (urine specimen containing creatinine and specific gravity levels inconsistent with human urine)
• Failure to cooperate with any part of the testing process